JP2016532674A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532674A5 JP2016532674A5 JP2016524845A JP2016524845A JP2016532674A5 JP 2016532674 A5 JP2016532674 A5 JP 2016532674A5 JP 2016524845 A JP2016524845 A JP 2016524845A JP 2016524845 A JP2016524845 A JP 2016524845A JP 2016532674 A5 JP2016532674 A5 JP 2016532674A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- nanoparticles
- physical
- medical system
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010028980 Neoplasm Diseases 0.000 claims 21
- 239000002105 nanoparticle Substances 0.000 claims 16
- 238000000034 method Methods 0.000 claims 14
- 230000002491 angiogenic effect Effects 0.000 claims 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 4
- 238000003384 imaging method Methods 0.000 claims 4
- 230000000717 retained effect Effects 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 238000001727 in vivo Methods 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 229910052742 iron Inorganic materials 0.000 claims 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 206010020843 Hyperthermia Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000002872 contrast media Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000036031 hyperthermia Effects 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13176364.1A EP2823858A1 (en) | 2013-07-12 | 2013-07-12 | System generating a constraint field, and medical device implementing the same |
| EP13176364.1 | 2013-07-12 | ||
| PCT/EP2014/064995 WO2015004285A1 (en) | 2013-07-12 | 2014-07-11 | System generating a constraint field, and medical device implementing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532674A JP2016532674A (ja) | 2016-10-20 |
| JP2016532674A5 true JP2016532674A5 (enExample) | 2017-07-20 |
| JP6534660B2 JP6534660B2 (ja) | 2019-06-26 |
Family
ID=48793929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016524845A Expired - Fee Related JP6534660B2 (ja) | 2013-07-12 | 2014-07-11 | 拘束場を生成するシステムおよびそれを実装する医療装置 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10449160B2 (enExample) |
| EP (2) | EP2823858A1 (enExample) |
| JP (1) | JP6534660B2 (enExample) |
| WO (1) | WO2015004285A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10660975B2 (en) | 2016-10-21 | 2020-05-26 | Nanobacterie | Magnetic nanoparticles for destroying pathological cells in an individual |
| EP4302820A3 (en) * | 2016-11-24 | 2024-03-06 | Public University Corporation Yokohama City University | Cancer treatment apparatus |
| WO2019104579A1 (en) * | 2017-11-30 | 2019-06-06 | SHIEH, Darbin | Method for predicting and modulating susceptibility of cancer cell to programmed cell death |
| EP4292660A1 (de) | 2022-06-13 | 2023-12-20 | Fortis GmbH | System zur verabreichung eines wirkstoffs |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4428851C2 (de) * | 1994-08-04 | 2000-05-04 | Diagnostikforschung Inst | Eisen enthaltende Nanopartikel, ihre Herstellung und Anwendung in der Diagnostik und Therapie |
| AU4305101A (en) * | 1999-11-22 | 2001-06-04 | Research Foundation Of The State University Of New York, The | Magnetic nanoparticles for selective therapy |
| AU2003900335A0 (en) * | 2003-01-22 | 2003-02-13 | Sirtex Medical Limited | Microparticles for selectively targeted hyperthermia |
| JP2009114066A (ja) * | 2006-02-24 | 2009-05-28 | International Medical Center Of Japan | 機能性分子が導入された有機磁性ナノ複合体 |
| FR2897931B1 (fr) * | 2006-02-24 | 2008-05-09 | Technologie Alpine De Securite | Dispositif de declenchement d'avalanche |
| EP1852107A1 (en) | 2006-04-19 | 2007-11-07 | Nanobiotix | Magnetic nanoparticles compositions and uses thereof |
| EP1988156A1 (en) * | 2007-04-30 | 2008-11-05 | Brossel, Rémy | Cell construct, its process of manufacture, as well as a device, implant and processes for the mechanical stimulation of cells in vitro and in vivo |
| WO2009076465A1 (en) * | 2007-12-11 | 2009-06-18 | University Of Maryland, College Park | Methods and systems for magnetic focusing of therapeutic, diagnostic or prophylactic agents to deep targets |
| DE102008008522A1 (de) | 2008-02-11 | 2009-08-13 | Magforce Nanotechnologies Ag | Implantierbare Nanopartikel-enthaltende Produkte |
| EP2508171B1 (en) | 2011-03-25 | 2014-05-07 | Universitätsklinikum Erlangen | Pharmaceutical magnetic nano-particle composition |
-
2013
- 2013-07-12 EP EP13176364.1A patent/EP2823858A1/en not_active Withdrawn
-
2014
- 2014-07-11 EP EP14738529.8A patent/EP3019236A1/en active Pending
- 2014-07-11 US US14/904,580 patent/US10449160B2/en not_active Expired - Fee Related
- 2014-07-11 JP JP2016524845A patent/JP6534660B2/ja not_active Expired - Fee Related
- 2014-07-11 WO PCT/EP2014/064995 patent/WO2015004285A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Włodarczyk et al. | Magnetite nanoparticles in magnetic hyperthermia and cancer therapies: Challenges and perspectives | |
| Cabrera et al. | Dynamical magnetic response of iron oxide nanoparticles inside live cells | |
| Del Sol-Fernández et al. | Flower-like Mn-doped magnetic nanoparticles functionalized with α v β3-integrin-ligand to efficiently induce intracellular heat after alternating magnetic field exposition, triggering glioma cell death | |
| Bayda et al. | Inorganic nanoparticles for cancer therapy: a transition from lab to clinic | |
| Oliveira et al. | Triggered release of paclitaxel from magnetic solid lipid nanoparticles by magnetic hyperthermia | |
| Qu et al. | Enhanced magnetic fluid hyperthermia by micellar magnetic nanoclusters composed of Mn x Zn1–x Fe2O4 nanoparticles for induced tumor cell apoptosis | |
| Chen et al. | Iron-loaded magnetic nanocapsules for pH-triggered drug release and MRI imaging | |
| Dabbagh et al. | Polyethylene glycol-coated porous magnetic nanoparticles for targeted delivery of chemotherapeutics under magnetic hyperthermia condition | |
| Sahoo et al. | Recent advancement of gelatin nanoparticles in drug and vaccine delivery | |
| Toropova et al. | In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles | |
| Kumeria et al. | Naturally derived iron oxide nanowires from bacteria for magnetically triggered drug release and cancer hyperthermia in 2D and 3D culture environments: bacteria biofilm to potent cancer therapeutic | |
| Gizzatov et al. | Hierarchically structured magnetic nanoconstructs with enhanced relaxivity and cooperative tumor accumulation | |
| Abdelaziz et al. | Silica-coated magnetic nanoparticles for vancomycin conjugation | |
| Friedrich et al. | SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications | |
| Narayanasamy et al. | Alternating current (AC) susceptibility as a particle-focused probe of coating and clustering behaviour in magnetic nanoparticle suspensions | |
| Nebu et al. | Erlotinib conjugated gold nanocluster enveloped magnetic iron oxide nanoparticles–A targeted probe for imaging pancreatic cancer cells | |
| Sanz et al. | Low-dimensional assemblies of magnetic MnFe2O4 nanoparticles and direct in vitro measurements of enhanced heating driven by dipolar interactions: implications for magnetic hyperthermia | |
| JP2016532674A5 (enExample) | ||
| Sharma et al. | A model for magnetic nanoparticles transport in a channel for targeted drug delivery | |
| Slabu et al. | Modeling of magnetoliposome uptake in human pancreatic tumor cells in vitro | |
| JP2020527545A5 (enExample) | ||
| Iglesias et al. | Simultaneous hyperthermia and doxorubicin delivery from polymer-coated magnetite nanoparticles | |
| Anwar et al. | Synthesis and in vitro localization study of curcumin-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system | |
| Caizer | Magnetic hyperthermia-using magnetic metal/oxide nanoparticles with potential in cancer therapy | |
| Fazilati | Folate decorated magnetite nanoparticles: Synthesis and targeted therapy against ovarian cancer |